Experience
Novartis Vaccines & Diagnostics, Inc.
MedImmune, LLC
Defended MedImmune, LLC in patent infringement litigation brought by Novartis Vaccines and Diagnostics, Inc. concerning recombinant DNA expression vectors; case ultimately resolved through confidential settlement.
Novartis Vaccines & Diagnostics, Inc. v. MedImmune, LLC, 1:11-cv-00084, D. Del., Judges Robinson, Thynge
Genetics Institute v. Novartis Vaccines and Diagnostics
Genetics Institute
Novartis Vaccines & Diagnostics, Inc. v. Institut Pasteur
Institut Pasteur
Cyberfone Systems, LLC v. Cellco Partnership
ZTE (USA) Inc.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
AbbVie Inc.
KeyMe, LLC v. The Hillman Group, Inc.
The Hillman Group, Inc.
HTC Corp.
Ventronics Systems, LLC v. Drager Medical GmbH
Maquet, Inc.
Genzyme Corporation et al. v. Novartis Gene Therapies, Inc. et al.
Novartis Gene Therapies, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.